TRIM24 and cancer: Cox proportional hazard modelling, adjusted for age, gender and smoking status, revealed that anti-TIF1-Ab positivity was significantly associated with a shorter time between DM and cancer onset (during the entire follow-up period) [HR 3.2 (95% CI 1.8, 5.5)].